Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 25, 2024, titled "Studies Show Sun Pharma s WINLEVI? (clascoterone) Cream 1% Reduces Sebum Levels and is Suitable for Combination With Other Commonly Used Topical Acne Medications".